(Q24806506)

English

On the probability of cost-effectiveness using data from randomized clinical trials

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

On the probability of cost-effectiveness using data from randomized clinical trials (English)

0 references

main subject

cost-effectiveness analysis

1 reference

A R Willan

1

0 references

language of work or name

English

0 references

publication date

2001

0 references

published in

BMC Medical Research Methodology

0 references

volume

1

0 references

issue

1

0 references

page(s)

8

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2288-1-8

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2288-1-8

cites work

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58837

retrieved

7 April 2017

On the (near) equivalence of cost-effectiveness and cost-benefit analyses

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58837

retrieved

28 September 2017

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58837

retrieved

30 May 2018

The interpretation of results of economic evaluation: explicating the value of health

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58837

retrieved

30 May 2018

Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58837

retrieved

30 May 2018

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

A Bayesian approach to stochastic cost-effectiveness analysis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

Incremental net benefit in randomized clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

A note on confidence intervals in cost-effectiveness analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2288-1-8

retrieved

21 January 2018

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11686854

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/1471-2288-1-8

0 references

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2288-1-8

0 references

0 references

ResearchGate publication ID

11666067

0 references

(Q24806506)

On the probability of cost-effectiveness using data from randomized clinical trials

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)